Identifying an early indicator of drug efficacy in patients (pts) with metastatic colorectal cancer (mCRC): A prospective evaluation of circulating tumor cells (CTC), 18F-fluorodeoxyglucose positron-emission tomography (PET), and the RECIST criteria.
Brigette Ma
No relevant relationships to disclose
Ann Dorothy King
No relevant relationships to disclose
LI Leung
No relevant relationships to disclose
Annette Poon
No relevant relationships to disclose
Ki Wang
No relevant relationships to disclose
Herbert H. F. Loong
No relevant relationships to disclose
Rosalie Ho
No relevant relationships to disclose
Frankie Mo
No relevant relationships to disclose
Wing Ming Ho
No relevant relationships to disclose
Charles Chan
No relevant relationships to disclose
Anthony T. C. Chan
No relevant relationships to disclose
Cesar SC Wong
No relevant relationships to disclose